Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesLaboratory/PathologyHealthfirst Urine Culture Coverage | OpenPayer
    Ask Trek AI about this page
    ModifiedHealthfirstPolicy PO-RE-013v6

    Urine Culture Testing for Bacteria

    Customize your policy alerts

    Sign up for Healthfirst Policy PO-RE-013v6 alerts

    Get alerted when Policy PO-RE-013v6 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs Healthfirst coverage of urine culture testing, including isolate identification and antibiotic susceptibility testing when applicable, for suspected urinary tract infection or bacteriuria. It applies to providers requesting reimbursement for urine cultures and distinguishes covered clinical indications from asymptomatic, follow-up, screening, and prostate-biopsy uses that do not meet coverage criteria.

    Policy Summary
    PayerHealthfirst
    PolicyUrine Culture Testing for Bacteria
    Policy CodePolicy PO-RE-013v6
    Change TypeModified
    Effective DateNov 1, 2026
    Next Review DateNot scheduled
    Key ActionDocument the clinical indication for the urine culture, including pregnancy, a planned mucosa-breaching urological intervention, pyelonephritis assessment, or at least one sign or symptom of possible UTI or bacteriuria.
    SourceLink

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    POLICY UPDATE CHANGES

    Expanded the listed signs and symptoms used to support urine culture coverage.

    Updated the policy background, guidelines, recommendations, and scientific references without changing coverage criteria.

    4Covered clinical indication categories
    3Explicit noncovered use categories
    8Applicable laboratory procedure codes
    PregnancyASB screening recommended population
    Avoid routine screeningAsymptomatic bacteriuria in nonpregnant populations

    Coverage Criteria

    Covered Indications

    Urine culture testing, including isolate identification and antibiotic susceptibility testing when applicable, meets coverage criteria when medically necessary for the covered indications below.

    ONE or more of the following

    • Pregnancy with suspected or asymptomatic bacteriuria/urinary tract infection.
    • An asymptomatic individual undergoing a urologic intervention that breaches the mucosa; testing must occur before the procedure.
    • At least one sign or symptom of a possible urinary tract infection or bacteriuria.
    • Assessment of suspected pyelonephritis, systemic urinary tract infection, or complicated urinary tract infection.
    • Suspected acute infective epididymitis, with appropriate urine specimens obtained for pathogen identification.
    • Diagnosis or management of bacterial prostatitis when urine culture is indicated, including acute bacterial prostatitis managed as a complicated urinary tract infection or chronic bacterial prostatitis evaluated with an appropriate localization test.
    • Urosepsis, when urine culture and blood cultures are obtained before antimicrobial treatment.

    Not Covered Indications

    Urine culture testing does not meet coverage criteria when performed solely for the following indications or circumstances.

    ONE or more of the following

    • Screening for or treatment of asymptomatic bacteriuria in populations for which routine screening is not recommended, including nonpregnant adults and children, unless a specifically covered indication applies.
    • Routine culture of an asymptomatic catheterized individual or an asymptomatic kidney transplant recipient outside a covered clinical indication.
    • Urine culture prompted only by pyuria, cloudy urine, or odorous urine in a catheterized individual, without compatible signs or symptoms of catheter-associated urinary tract infection.
    • Initial screening for asymptomatic prostatitis.
    • Assessment or prognosis of prostate biopsy.

    Adult Symptomatic, Complicated, or Systemic Infection

    For adults, urine culture testing meets coverage criteria when ALL of the following are met:

    ALL of the following

    • The individual has a clinically relevant indication for culture, such as urinary symptoms, systemic illness, suspected complicated infection, or suspected upper-tract infection.
    • ONE or more of the following clinical situations is present

      • Symptoms or signs of a possible urinary tract infection or bacteriuria, including dysuria, urinary frequency, urgency, suprapubic pain, gross hematuria, or other clinically compatible symptoms.
      • Suspected acute pyelonephritis or systemic urinary tract infection.
      • Symptoms that do not resolve or recur within four weeks after completion of treatment.

    Pregnancy and Mucosa-Traumatizing Urologic Procedures

    Urine culture testing meets coverage criteria for asymptomatic bacteriuria when ALL of the following are met:

    ALL of the following

    • The individual has a high-risk indication for screening or treatment of asymptomatic bacteriuria.
    • ONE of the following

      • The individual is pregnant.
      • The individual is undergoing a urologic procedure or intervention expected to breach the urinary tract mucosa or cause mucosal bleeding; culture is obtained before the procedure.

    Pediatric Urine Culture Evaluation

    In children, urine culture testing meets coverage criteria when ALL of the following are met:

    ALL of the following

    • The child has a clinical or urinalysis finding that warrants evaluation for urinary tract infection.
    • ONE or more of the following

      • A febrile infant or child, particularly an infant 2 to 36 months old with fever greater than 39°C and no other source of fever.
      • Age under 3 months or high-to-intermediate risk of serious illness.
      • Suspected acute upper urinary tract infection or pyelonephritis.
      • Positive leukocyte esterase, nitrite, microscopic leukocytes, or bacteria on urinalysis.

    Urosepsis, Prostatitis, and Epididymitis

    Urine culture testing meets coverage criteria for selected lower genitourinary or systemic infections when ALL of the following are met:

    ALL of the following

    • The clinical presentation supports one of the infections below.
    • ONE of the following

      • Urosepsis is suspected; obtain a urine culture and two sets of blood cultures before antimicrobial treatment.
      • Acute bacterial prostatitis is suspected; culture is performed as part of management of a complicated urinary tract infection.
      • Chronic bacterial prostatitis is suspected; perform an appropriate Meares and Stamey 2- or 4-glass localization test rather than relying on ejaculate analysis alone.

    Urine culture testing, with isolate identification and antibiotic susceptibilities if applicable, does not meet coverage criteria when performed as part of initial screening for asymptomatic prostatitis.

    Urine culture testing, with isolate identification and antibiotic susceptibilities if applicable, does not meet coverage criteria when performed for assessment or prognosis of prostate biopsy.

    Routine screening for or treatment of asymptomatic bacteriuria does not meet coverage criteria in nonpregnant individuals, including healthy premenopausal or postmenopausal individuals, individuals with diabetes, older community-dwelling or long-term-care residents, individuals with spinal cord injury, individuals with nonrenal solid-organ transplants, and individuals undergoing elective nonurologic surgery. Screening is also not routinely covered for renal transplant recipients more than one month after transplant, unless another covered indication applies. High-risk neutropenia has no established recommendation for or against screening; it is not a routine covered screening indication.

    Asymptomatic bacteriuria screening and treatment are covered in pregnancy and before endoscopic or other urologic procedures associated with mucosal trauma, as specified above.

    Routine urine culture does not meet coverage criteria for asymptomatic catheterized individuals, including those with short-term indwelling urethral catheters, or for asymptomatic kidney transplant recipients more than two months after transplantation. Culture of an asymptomatic kidney transplant recipient should not be routinely collected or used to guide treatment unless a covered indication applies.

    Pyuria alone is not sufficient to establish catheter-associated urinary tract infection. Cloudy or odorous urine alone also does not establish catheter-associated urinary tract infection or justify urine culture testing.

    When acute scrotal pain or swelling is due to suspected testicular torsion, urine culture is not indicated; urgent surgical evaluation is required instead.

    Urine culture testing for other asymptomatic urinary tract infection or asymptomatic bacteriuria not specifically described as a covered indication does not meet coverage criteria.

    Follow-up urine culture testing after treatment of an uncomplicated urinary tract infection does not meet coverage criteria when the individual shows clinical resolution of infection. Clinical resolution is sufficient to assess treatment effectiveness in this setting.

    Applicable Codes and Clinical Thresholds

    Applicable CodesCPT
    87077Culture, bacterial; aerobic isolate, additional methods required for definitive identification, each isolate.
    87086Culture, bacterial; quantitative colony count, urine.
    87088Culture, bacterial; with isolation and presumptive identification of each isolate, urine.
    87140Culture, typing; immunofluorescent method, each antiserum.
    87147Culture, typing; immunologic method, other than immunofluorescence (e.g., agglutination grouping), per antiserum.
    87149Culture, typing; identification by nucleic acid (DNA or RNA) probe, direct probe technique, per culture or isolate, each organism probed.
    87181Susceptibility studies, antimicrobial agent; agar dilution method, per agent (e.g., antibiotic gradient strip).
    87186Susceptibility studies, antimicrobial agent; microdilution or agar dilution (minimum inhibitory concentration [MIC] or breakpoint), each multi-antimicrobial, per plate.
    Applicable CPT CodesCPT
    87077Culture, bacterial; aerobic isolate, additional methods required for definitive identification, each isolate.
    87086Culture, bacterial; quantitative colony count, urine.
    87088Culture, bacterial; with isolation and presumptive identification of each isolate, urine.
    87140Culture, typing; immunofluorescent method, each antiserum.
    87147Culture, typing; immunologic method, other than immunofluorescence (e.g., agglutination grouping), per antiserum.
    87149Culture, typing; identification by nucleic acid (DNA or RNA) probe, direct probe technique, per culture or isolate, each organism probed.
    87181Susceptibility studies, antimicrobial agent; agar dilution method, per agent (e.g., antibiotic gradient strip).
    87186Susceptibility studies, antimicrobial agent; microdilution or agar dilution (minimum inhibitory concentration [MIC] or breakpoint), each multi-antimicrobial, per plate.
    Pediatric fever
    Fever threshold>39 °C
    Age rangeInfants 2 to 36 months
    Additional conditionNo other source of fever on history or physical examination
    High-risk neutropenia
    Absolute neutrophil count<100 cells/mm3
    Duration≥7 days
    Clinical contextFollowing chemotherapy

    Provider Documentation and Action Requirements

    Documentation Required

    Clinical Indication Required

    Document the clinical indication supporting urine culture testing. Coverage criteria are met for a pregnant individual, an asymptomatic individual undergoing a urological intervention that breaches the mucosa, an individual with at least one sign or symptom of possible UTI or bacteriuria, or assessment of pyelonephritis.

    • Record the relevant diagnosis, symptom, pregnancy status, planned mucosa-breaching urological procedure, or suspected pyelonephritis in the medical record.
    Documentation Required

    Document Culture Results

    When urine culture testing is performed, document isolate identification and antibiotic susceptibility testing when applicable.

    • Include the culture result, identified organism or isolate, and susceptibility findings when performed or clinically applicable.

    Clinical Background

    Urinary tract infections may be symptomatic or asymptomatic and can involve the bladder, kidneys, urethra, prostate, or epididymis, or progress to urosepsis. Urine culture can detect and characterize bacterial infection, but bacteriuria or pyuria alone does not establish symptomatic infection. Avoiding unnecessary cultures and treatment of asymptomatic bacteriuria supports antimicrobial stewardship by reducing adverse drug events and antimicrobial resistance.

    Clinical Definitions

    Bacteriuria
    DefinitionThe presence of bacteria in the urine.
    May occur withSymptomatic or asymptomatic urinary tract infection
    InterpretationBacteriuria alone does not establish symptomatic infection.
    Cystitis
    DefinitionAn infection of the bladder or lower urinary tract.
    ClassificationA type of urinary tract infection
    Related conditionsUrinary tract infections may be symptomatic or asymptomatic.

    Covered Clinical Indications

    Pregnancy With Suspected UTI

    Covered when ALL of the following are met:

    Pregnancy with suspected UTI

    • The individual is pregnant.
    • A urinary tract infection or bacteriuria is suspected or being evaluated.
    • Urine culture is performed, with isolate identification and antibiotic susceptibility testing when applicable.

      For asymptomatic bacteriuria screening in pregnancy, midstream urine culture is the recommended or gold-standard method.

    Asymptomatic Individual Undergoing a Mucosa-Breaching Urological Intervention

    Covered when ALL of the following are met:

    Preprocedure screening

    Specimen Collection and Ordering Requirements

    Step Therapy

    Follow pediatric urine collection requirements

    For pediatric specimens, collect urine by catheterization or suprapubic aspiration when specified; a toilet-trained child may provide a midstream specimen. When culture is indicated for suspected infection, collect the urine before starting antibiotics whenever possible.

    • For suspected infective epididymitis, obtain both midstream and first-voided urine for culture and nucleic acid amplification testing.
    • Do not rely on a bag-collected urine culture to establish UTI in the cited febrile infant guidance.

    Noncovered Uses

    Other asymptomatic UTI or asymptomatic bacteriuria not described as a covered indication is not covered.

    A follow-up urine culture after treatment of an uncomplicated UTI is not covered when clinical resolution has occurred.

    Initial screening for asymptomatic prostatitis is not covered.

    Assessment or prognosis of prostate biopsy is not covered.

    Policy Summary
    PayerHealthfirst
    PolicyUrine Culture Testing for Bacteria
    Policy CodePolicy PO-RE-013v6
    Change TypeModified
    Effective DateNov 1, 2026
    Next Review DateNot scheduled
    Key ActionDocument the clinical indication for the urine culture, including pregnancy, a planned mucosa-breaching urological intervention, pyelonephritis assessment, or at least one sign or symptom of possible UTI or bacteriuria.
    SourceLink
    On This Page
    Coverage CriteriaApplicable Codes and Clinical ThresholdsProvider Documentation and Action RequirementsClinical BackgroundClinical DefinitionsCovered Clinical IndicationsSpecimen Collection and Ordering RequirementsNoncovered Uses
  1. Urine culture when suspected testicular torsion explains acute scrotal pain or swelling.
  2. Follow-up culture after treatment of an uncomplicated urinary tract infection when clinical resolution has occurred.
  3. Any other asymptomatic urinary tract infection or asymptomatic bacteriuria not specifically described as covered.
  4. Atypical urinary symptoms.
  5. Complicated urinary tract infection, including infection associated with diabetes, immunosuppression, obstruction, incomplete voiding, vesicoureteral reflux, recent instrumentation, male sex, pregnancy, or healthcare-associated infection.
  6. Recurrent symptomatic urinary tract infection requiring culture for diagnosis or management.
  7. A febrile infant who appears ill or otherwise requires immediate antimicrobial therapy; urine is obtained for urinalysis and culture before antibiotics.
  8. A child who is not in a low-risk group for urinary tract infection and whose urinalysis suggests infection.
  9. Recurrent urinary tract infection.
  10. Clinical symptoms or signs are present but dipstick findings do not correlate.
  11. Infection does not respond to treatment within 24 to 48 hours when no prior urine sample was sent.
  12. Antibiotic treatment is required immediately for another indication, such as suspected bacteremia, requiring urine collection for urinalysis, microscopy, and culture before antibiotics.
  13. Acute infective epididymitis is suspected; obtain a midstream urine and first-void urine for pathogen identification by culture and nucleic acid amplification testing.
    Renal transplant timing
    Timing>1 month after renal transplant surgery
    RecommendationAgainst screening for asymptomatic bacteriuria
    Treatment recommendationAgainst treating asymptomatic bacteriuria
    Kidney transplant timing
    Timing>2 months after kidney transplant
    PopulationAsymptomatic kidney transplant recipients
    RecommendationAgainst routinely collecting urine culture or treating bacteriuria
    Pediatric treatment response
    Response timeframeNo response within 24 to 48 hours
    PopulationBabies and children with suspected urinary tract infection
    Further evaluationSend a urine sample for culture if infection does not respond to treatment and no sample has already been sent
    Documentation Required

    Document the Clinical Indication

    Associate urine culture testing with documented symptoms, suspected infection, or another covered clinical indication. Testing may support suspected UTI or bacteriuria, pyelonephritis, complicated or systemic UTI, atypical symptoms, recurrent or unresolved symptoms, urethritis or urosepsis when clinically indicated, and pediatric findings meeting applicable criteria.

    • Document bladder symptoms such as dysuria, frequency, urgency, hematuria, suprapubic or groin pressure, or cramping.
    • Document kidney or systemic findings such as fever, chills, flank or lower-back pain, nausea, vomiting, or suspected pyelonephritis.
    • Document atypical presentations, recurrent symptoms, symptoms that fail to resolve or recur after treatment, complicated UTI risk factors, or other findings supporting infection.
    • For children, document age, fever and other age-appropriate findings, including poor feeding, irritability, vomiting, accidents or bedwetting, painful urination, abdominal or flank pain, foul-smelling or cloudy urine, hematuria, or fever and chills.

    Unsupported block type: documentation

    Unsupported block type: denial_risk

    Denial Risk

    Routine Post-Treatment Culture Not Covered

    Do not order a routine follow-up urine culture after treatment of an uncomplicated UTI when the individual shows clinical resolution of infection.

    • Clinical resolution is sufficient for determining effectiveness of therapy in an uncomplicated UTI.
    Denial Risk

    Covered Indication Required

    Before ordering urine culture testing, document and link the test to a covered clinical indication. Covered indications include pregnancy, a mucosa-breaching urological intervention, at least one sign or symptom of possible UTI or bacteriuria, or assessment of pyelonephritis.

    • A culture ordered without a documented covered indication may not meet coverage criteria and may be denied.

    Unsupported block type: denial_risk

    Unsupported block type: denial_risk

    Unsupported block type: denial_risk

    Billing Rule

    Coding and Billing Compliance

    Follow Healthfirst and applicable national, federal, state, payer, coding, billing, and reimbursement requirements when submitting claims. Failure to follow applicable requirements may result in claim denial or recoupment of payment.

    • Apply NCCI, NCD/LCD, modifier, global surgery, multiple-procedure, medically unlikely edit, duplicate, CPT, HCPCS, ICD-10, revenue-code, CPT Assistant, and applicable New York State requirements.
    • Use accurate coding and documentation that support the billed service and the covered clinical indication.
    Pyelonephritis
    DefinitionAn infection of the upper urinary tract or kidney.
    ClassificationA type of urinary tract infection
    Culture contextUrine culture is recommended for suspected acute pyelonephritis or systemic urinary tract infection.
    Uncomplicated UTI
    DefinitionAn acute, sporadic, or recurrent cystitis limited to a nonpregnant individual.
    Anatomic and functional criteriaNo known relevant anatomical or functional abnormalities within the urinary tract
    Comorbidity criteriaNo relevant comorbidities
    Complicated UTI
    DefinitionA UTI with an increased chance of a complicated course.
    Associated populations and conditionsMen, pregnant individuals, people with relevant urinary-tract abnormalities, or people with indwelling urinary catheters
    Additional risk factorsRenal disease or immunocompromising comorbidities, such as diabetes
    Bacteriuria threshold
    Quantitative threshold10^5 bacteria per milliliter of urine
    Use in policy discussionDefinition used in discussing bacteriuria and urine-culture reliability
    Single positive culture reliability80%
    Complicated urinary tract infection (cUTI)
    DefinitionA UTI in which host factors or urinary-tract anatomic or functional abnormalities are expected to make infection more difficult to eradicate than an uncomplicated infection.
    Host factorsUnderlying diabetes or immunosuppression
    Urinary-tract factorsObstruction or incomplete voiding due to detrusor muscle dysfunction
    Other associated factorsVesicoureteral reflux, recent instrumentation, male sex, pregnancy, or healthcare-associated infection
    Asymptomatic bacteriuria (ASB)
    DefinitionBacteriuria in the absence of urinary symptoms.
    General recommendationDo not routinely screen for or treat asymptomatic bacteriuria in most populations.
    Selected exceptionsScreening and treatment are recommended or supported during pregnancy and before urologic procedures that breach the mucosa.
    Uncomplicated cystitis
    DefinitionA clinical syndrome characterized by dysuria plus one or more additional urinary symptoms.
    Additional symptomsUrinary frequency, urgency, suprapubic pain, or gross hematuria
    Clinical contextThe syndrome is used to identify uncomplicated cystitis rather than relying on asymptomatic bacteriuria alone.
    • The individual is asymptomatic.
    • The individual is scheduled for an endoscopic or other urological intervention that breaches the urinary mucosa or causes mucosal trauma.
    • Urine culture is obtained before the intervention.before the procedure

      Screening and treatment of asymptomatic bacteriuria are supported in this setting.

    At Least One Sign or Symptom of Possible UTI or Bacteriuria

    Covered when the individual has at least one sign or symptom of possible UTI or bacteriuria. Symptoms should be documented according to the individual's age and clinical context.

    Clinical signs or symptoms

    • At least one sign or symptom of possible UTI or bacteriuria is present.
    • The sign or symptom is documented using the applicable age- and population-specific criteria for infants and toddlers, older children, adults, older frail individuals, individuals with urinary catheters, or immunocompromised individuals.

    Assessment of Pyelonephritis

    Covered when ALL of the following are met:

    Assessment of pyelonephritis

    • Pyelonephritis or an upper urinary tract infection is suspected or being assessed.
    • Urine culture is obtained, with antimicrobial susceptibility testing when applicable or recommended.

      The EAU recommends urine culture and antimicrobial susceptibility testing for pyelonephritis.

    Urine Culture for Selected Urinary and Genitourinary Infections

    Urine culture is covered for ANY of the following clinical indications. Collect the specimen before antimicrobial treatment whenever feasible.

    Covered clinical indications

    • Suspected pyelonephritis or systemic UTI; antimicrobial susceptibility testing is recommended with pyelonephritis.
    • Complicated UTI, including infection associated with relevant host factors or urinary-tract anatomic or functional abnormalities.
    • Urosepsis; obtain urine culture and two sets of blood cultures before antimicrobial treatment.
    • Recurrent symptomatic UTI.
    • Persistent or recurrent symptoms, including symptoms that do not resolve or recur within four weeks after treatment.
    • Atypical urinary or cystitis symptoms.
    • Pregnancy.
    • A selected pediatric presentation supporting culture, including suspected pyelonephritis or serious illness, age under 3 months, recurrent UTI, abnormal urinalysis in an appropriately aged febrile child, treatment failure within 24 to 48 hours, or symptoms inconsistent with dipstick findings.
    • Bacterial prostatitis requiring culture, including chronic bacterial prostatitis evaluated with Meares and Stamey testing or acute bacterial prostatitis managed as complicated UTI.
    • Suspected acute infective epididymitis; obtain midstream and first-voided urine for culture and nucleic acid amplification testing.

    Screening for Asymptomatic Bacteriuria During Pregnancy

    Covered when ALL of the following are met:

    Pregnancy ASB screening

    • The individual is pregnant.
    • Screening for asymptomatic bacteriuria is being performed.
    • A midstream urine culture is obtained.

      Midstream urine culture is the recommended or gold-standard diagnostic method for asymptomatic bacteriuria in pregnancy.

    Screening for and Treating Asymptomatic Bacteriuria Before Mucosa-Traumatizing Urologic Procedures

    Covered when ALL of the following are met:

    Preprocedural ASB screening and treatment

    • The individual is asymptomatic.
    • The individual is scheduled for an endoscopic urological procedure associated with mucosal trauma or an intervention expected to breach the urinary mucosa.
    • Urine culture is obtained before the intervention.before the intervention

      Screening for and treatment of asymptomatic bacteriuria are recommended before the procedure.